Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortality

被引:12
|
作者
Henao-Martinez, Andres F. [1 ,5 ]
Corbisiero, Michaele Francesco [1 ]
Salter, Ixchel [1 ]
Chastain, Daniel B. [2 ]
Thompson III, George R. [3 ,4 ]
机构
[1] Univ Colorado, Dept Med, Div Infect Dis, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Univ Georgia, Dept Clin & Adm Pharm, Coll Pharm, Albany, GA 31701 USA
[3] Univ Calif Sacramento, Davis Med Ctr, Dept Med, Div Infect Dis, Sacramento, CA 95817 USA
[4] Univ Calif Sacramento, Davis Med Ctr, Dept Med Microbiol & Immunol, Sacramento, CA 95817 USA
[5] Univ Colorado, Anschutz Med Campus, 12700,19th Ave,Mail Stop B168, Aurora, CO 80045 USA
关键词
Aspergillus; invasive pulmonary aspergillosis; mortality; drug therapy; VORICONAZOLE; INFECTIONS; DIAGNOSIS; PHASE-3;
D O I
10.1093/mmy/myad074
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Invasive pulmonary aspergillosis (IPA) is a severe fungal infection that primarily affects immunocompromised patients and is associated with high mortality. Contemporary clinical characteristics of IPA and "real-world" estimates and predictors of associated mortality are inadequate. TriNetX, a global research network, was queried to identify adult patients with IPA diagnoses based on the ICD-10 code B44.0. We performed a propensity score-matched analysis comparing clinical characteristics among patients who survived versus non-survivors at 1 year. We identified 4371 patients with IPA. We found neoplasms, solid organ transplant recipients, hematologic malignancies, and aplastic anemia as the most predominant risk factors. The overall 1-year mortality was 32% for IPA. 1-year mortality was highest for patients with COVID-19 in the ICU, followed by those with acute myeloid leukemia and aplastic anemia (54%, 50%, and 39%, respectively). After propensity score matching, severe sepsis, pleural effusion, and candidiasis were mortality contributors within a year after diagnosis. Liver injury, systemic glucocorticoid exposure over the previous 6 months, lower lymphocyte and CD4 counts, elevated ferritin, LDH, thrombocytopenia, anemia, or elevated glycosylated hemoglobin (HbA1c) were independent predictors of mortality at 1 year. Voriconazole was the most common treatment (67%). The annual incidence of IPA was 0.001%, increasing to 0.02% among critically ill patients in the ICU. IPA continues to have a very high mortality. We encourage prospective studies to validate and refine the identified clinical markers linked to increased mortality. Lay Summary Invasive pulmonary aspergillosis (IPA) is common among immunocompromised patients. Analyzing a global research network, we found 32% of patients with IPA died a year after diagnosis. We identified the primary underlying conditions, contributors, and predictors of mortality.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study
    Chen, Jiajia
    Yang, Qing
    Huang, Jianrong
    Li, Lanjuan
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (12): : 1625 - 1631
  • [32] Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients
    Lao, Minxi
    Zhang, Kaicong
    Zhang, Meng
    Wang, Qian
    Li, Jin
    Su, Lei
    Ding, Meilin
    He, Wen
    Gong, Yingying
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 3525 - 3534
  • [33] Follow-up of Surgical and Nonsurgical Patients With Pulmonary Aspergillosis: A Real-World Study
    Chen, Zhifeng
    Shang, Yulin
    Wasti, Binaya
    Ou, Yanru
    Gong, Subo
    Xiang, Xudong
    Ouyang, Ruoyun
    Ouyang, Ruoyun
    INFECTION AND DRUG RESISTANCE, 2025, 18 : 1059 - 1070
  • [34] Epidemiology and Clinical outcomes of Invasive Pulmonary Aspergillosis: A Nationwide Multicenter Study in Korea
    Kim, Sung-Han }
    Moon, Song Mi
    Han, Sang Hoon
    Chung, Jin-Won
    Moon, Soo-youn
    Lee, Mi Suk
    Choo, Eun Ju
    Choi, Young Hwa
    Kim, Shin Woo
    Bae, In-Gyu
    Kwon, Hyun Hee
    Peck, Kyong Ran
    Kim, Yang Soo
    INFECTION AND CHEMOTHERAPY, 2012, 44 (04) : 282 - 288
  • [35] Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis
    Fischer, Tim
    El Baz, Yassir
    Graf, Nicole
    Wildermuth, Simon
    Leschka, Sebastian
    Kleger, Gian-Reto
    Pietsch, Urs
    Frischknecht, Manuel
    Scanferla, Giulia
    Strahm, Carol
    Walti, Stephan
    Dietrich, Tobias Johannes
    Albrich, Werner C.
    DIAGNOSTICS, 2022, 12 (05)
  • [36] Clinical Risk Score for Invasive Pulmonary Aspergillosis in Patients With Liver Failure: A Retrospective Study in Zhejiang
    Zhang, Xuan
    Shen, Sijia
    Dai, Xiahong
    Bi, Yunjiao
    Zhang, Junjie
    Wu, Yuhao
    Shi, Yishang
    Wei, Runan
    Gao, Hainv
    FRONTIERS IN MEDICINE, 2021, 8
  • [37] Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
    Wuyts, Wim A.
    Dahlqvist, Caroline
    Slabbynck, Hans
    Schlesser, Marc
    Gusbin, Natacha
    Compere, Christophe
    Maddens, Sofie
    Lee, Yuan-Chi
    Kirchgaessler, Klaus-Uwe
    Bartley, Karen
    Bondue, Benjamin
    RESPIRATORY RESEARCH, 2019, 20 (01)
  • [38] Factors associated with pulmonary complications after hepatectomy and establishment of nomogram: A real-world retrospective study
    Han, Kunyu
    Liu, Hui
    Bai, Ruiping
    Li, Jiarui
    Zhang, Linjuan
    An, Rui
    Peng, Di
    Zhao, Jiamin
    Xue, Mengwen
    Shen, Xin
    INDIAN JOURNAL OF ANAESTHESIA, 2025, 69 (02) : 225 - 235
  • [39] Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study
    Hoenigl, Martin
    Prattes, Juergen
    Neumeister, Peter
    Woelfler, Albert
    Krause, Robert
    MYCOSES, 2018, 61 (03) : 201 - 205
  • [40] Clinical Features and Prognosis of Invasive Pulmonary Aspergillosis in Korean Children with Hematologic/Oncologic Diseases
    Han, Seung Beom
    Kim, Seong Koo
    Bae, E. Young
    Lee, Jae Wook
    Yoon, Jong-Seo
    Chung, Nack-Gyun
    Cho, Bin
    Jeong, Dae Chul
    Kang, Jin Han
    Kim, Hack-Ki
    Lee, Dong-Gun
    Lee, Hyun Sil
    Im, Soo Ah
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (08) : 1121 - 1128